Together, these data demonstrate that the contribution of FUS-CHOP expression to myxoid liposarcoma cell growth is significant and that targeting the fusion gene and/or its downstream targets such as VEGFR1 and PDGFRα induces significant inhibition of myxoid liposarcoma tumor growth. This evidence concerns the gene DDIT3 and myxoid liposarcoma.